Further, tumor characteristics such as site of disease, number of disease sites, tumor grade, hormone sensitivity, human epidermal growth factor receptor-2 (HER2) status and other biological characteristics are likely to be responsible. This evidence concerns the gene ERBB2 and neoplasm.